Worksport Ltd (WKSP): Nasdaq/NYSE listing notice — Worksport receives Nasdaq bid price deficiency notice; has 180 days to regain compliance

Worksport Ltd

On April 19, 2024, Nasdaq notified Worksport that its common stock failed to maintain $1.00 minimum bid for 30 consecutive trading days.
The deficiency period was March 7, 2024 to April 18, 2024.
Worksport has until October 16, 2024 to regain compliance by closing at or above $1.00 for 10 consecutive trading days.
If not compliant by then, Worksport may be eligible for an additional 180 days if it meets other listing standards.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.98

Worksport Ltd received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

April 19, 2024, Worksport Ltd. (the “Company”) received written notice from The Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that it had failed to maintain a minimum bid price of at least $1.00 per share for the prior 30 consecutive trading day period from March 7, 2024 to April 18, 2024, based upon the closing bid price for its common stock as required by Nasdaq Listing Rule 5550(a)(2). Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has 180 calendar days, or until October 16, 2024, to regain compliance with the minimum bid requirement under Nasdaq Listing Rule 5550(a)(

View on SEC.gov

94 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Worksport Ltd filing history →

Source: SEC EDGAR

accession 0001493152-24-015714

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.